Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Merck KGaA Rebounds After COVID-19 Lockdowns
Mavenclad And Fertility Business Back On Track
Sep 17 2020
•
By
Kevin Grogan
Merck Sticking To €2bn pharma sales target by 2022 • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business